Impact of race on biochemical disease recurrence after prostate brachytherapy
Open Access
- 20 June 2011
- Vol. 117 (24), 5589-5600
- https://doi.org/10.1002/cncr.26183
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databasesProstate Cancer and Prostatic Diseases, 2009
- Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate BrachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology GroupJNCI Journal of the National Cancer Institute, 2009
- Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomyCancer, 2007
- Black Race Does Not Independently Predict Adverse Outcome Following Radical Retropubic Prostatectomy at a Tertiary Referral CenterJournal of Urology, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- RESPONSE: Re: Association of African-American Ethnic Background With Survival in Men With Metastatic Prostate CancerJNCI Journal of the National Cancer Institute, 2001
- Survival in Blacks and Whites After Treatment for Localized Prostate CancerJournal of Urology, 1996
- The prognostic significance of race and survival from prostate cancer based on patients irradiated on radiation therapy oncology group protocols (1976–1985)International Journal of Radiation Oncology*Biology*Physics, 1992